Skip to content Skip to sidebar Skip to footer

Gilead Sciences

Cognizant expands partnership with the biopharma industry firm Gilead, estimated deal size at $800 million

Cognizant declared the growth of its partnership with biopharmaceutical firm Gilead Sciences for an additional five years, which includes renewal and growth of Cognizant's services, for a total projected value of $800 million. Under the deal, the NASDAQ-listed IT firm will manage Gilead’s global IT infrastructure, platforms, applications, and advanced analytics and lead initiatives to…

Read More

EVERSANA & Amazon Web Services to “Pharmatize” Artificial Intelligence across the Life Sciences Industry

EVERSANA, a leading provider of commercial services to the global life sciences industry, announced that it will team up with Amazon Web Services (AWS) to accelerate generative artificial intelligence (AI) use cases across the life sciences industry. Together, the organisations will seek to harness the power of generative AI to help pharmaceutical and life science manufacturers drive…

Read More

Gilead expands IT partnership with Cognizant in deal worth approximately $800m

Gilead Sciences has expanded its existing collaboration with IT company Cognizant in a bid to more quickly bring drugs to market, with the new five-year service agreement worth approximately $800m. The partnership will see Cognizant manage Gilead's global IT infrastructure, platforms, applications and advanced analytics, and take charge of initiatives designed to accelerate the US…

Read More

Cognizant and Gilead Sciences Forge an AI-Driven Partnership to Advance Healthcare Technology

Cognizant has announced an extension of its partnership with Gilead Sciences, which will see Cognizant lead digital transformation at Gilead, among additional expansions, for a total expected value of US$800m over the following five years. Gilead will use these advancements to market medicine for HIV, viral hepatitis and cancer. A partnership to advance healthcare technology…

Read More

Cognizant Extends Collaboration With Gilead Sciences for Digital Transformation

by Ty Trumbull • Jul 24, 2023 Cognizant has expanded its collaboration with Gilead Sciences, a prominent biopharmaceutical company, in a partnership valued at $800 million over the next five years. The new agreement involves Cognizant managing Gilead’s global IT infrastructure, platforms, applications, and advanced analytics, with a focus on accelerating its digital transformation. The…

Read More